Merck Chairman and CEO Rob Davis joins 'Mad Money' host Jim Cramer to talk quarterly results, Keytruda sales, the company's turnaround story, and more. Got a confidential news tip? We want to hear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results